Skip to Content

93 3145 93 3145 (Cephalexin Monohydrate 250 mg)

Pill with imprint 93 3145 93 3145 is Gray & Red, Capsule-shape and has been identified as Cephalexin Monohydrate 250 mg. It is supplied by Teva Pharmaceuticals USA.

Cephalexin is used in the treatment of bladder infection; bacterial infection; bacterial endocarditis prevention; bone infection; kidney infections and belongs to the drug class first generation cephalosporins. There is no proven risk in humans during pregnancy. Cephalexin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 3145 93 3145

Cephalexin monohydrate 250 mg 93 3145 93 3145 Front
Cephalexin monohydrate 250 mg 93 3145 93 3145 Back
Cephalexin monohydrate 250 mg 93 3145 93 3145 Front
Cephalexin monohydrate 250 mg 93 3145 93 3145 Back
Cephalexin monohydrate 250 mg 93 3145 93 3145

Cephalexin Monohydrate

Imprint
93 3145 93 3145
Strength
250 mg
Color
Gray & Red
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
First generation cephalosporins
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-3145
Inactive Ingredients
magnesium stearate, silicon dioxide, sodium starch glycolate type A potato, ferrosoferric oxide, D&C Yellow No. 10, aluminum oxide, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, gelatin, sodium lauryl sulfate, titanium dioxide, propylene glycol, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.